A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range
Clinical trial NCT05671653 · TERMINATED
Trial details
- NCT number
- NCT05671653
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-19
- Primary completion
- 2023-11-03
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.